| Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc |
| Journal website https://jnr.elmerpub.com |
Case Report
Volume 16, Number 2, June 2026, pages 122-126
Adult-Onset Reversible Splenial Lesion Syndrome: A Case Series and Review of Age-Related Differences
Figure

Table
| Case | Age/sex | Clinical presentation | Underlying/associated condition | MRI findings | Treatment | Outcome |
|---|---|---|---|---|---|---|
| MRI: magnetic resonance imaging; RESLES: reversible splenial lesion syndrome; SCC: splenium of the corpus callosum. | ||||||
| 1 | 46/M | Fever and acute respiratory symptoms, later headache, slurred speech, and hearing loss | Lower respiratory tract infection | Splenial lesion type 1, limited to SCC | Antibiotics for respiratory infection | Clinical improvement within 1 week; full hearing recovery at 10 months |
| 2 | 29/F | Headache and blurred vision | Chronic renal failure later extensive cerebral venous thrombosis | Initial SCC lesion type 1, later extensive thrombophlebitis with hemorrhagic transformation | Ventriculoperitoneal shunt. Anticoagulation | Complete regression of SCC lesion and thrombosis at 6 months |
| 3 | 31/M | Acute abdominal pain and gastrointestinal bleeding. Drowsiness, dysarthria, limb ataxia, and postural tremors | Acute pancreatitis, acute renal failure | SCC lesion consistent with RESLES type 2 and acute encephalopathy | Blood transfusion, hemodialysis, dual antibiotics | Favorable evolution, cerebellar symptoms resolved within 1 month |
| 4 | 29/F | Drowsiness, headache, slurred speech, later after delivery insomnia and agitation | Peri/postpartum state | Splenial lesion of the corpus callosum type 1 | Risperidone | Complete recovery at 2-month follow-up |
| 5 | 30/F | A unique seizure then remained asymptomatic | Burkitt lymphoma with massive multivisceral involvement | Splenial lesion consistent with RESLES type 2 with no CNS infiltration | Chemotherapy | Remained neurologically asymptomatic at the latest follow-up |